Search

Your search keyword '"Ulrika Andersson"' showing total 75 results

Search Constraints

Start Over You searched for: Author "Ulrika Andersson" Remove constraint Author: "Ulrika Andersson" Topic female Remove constraint Topic: female
75 results on '"Ulrika Andersson"'

Search Results

1. Exercise, aerobic fitness, and muscle strength in relation to glucose tolerance 6 to 10 years after gestational diabetes

2. Body Composition During Pregnancy: Longitudinal Changes and Method Comparisons

3. Longitudinal changes in adipokines and free leptin index during and after pregnancy in women with obesity

4. Environmental factors influence the epigenetic signature of newborns from mothers with gestational diabetes

5. Physical activity during pregnancy and association with changes in fat mass and adipokines in women of normal-weight or with obesity

6. Growth-differentiation-factor 15 levels in obese and healthy pregnancies: Relation to insulin resistance and insulin secretory function

7. Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy

8. Pregnancy-induced changes in serum concentrations of perfluoroalkyl substances and the influence of kidney function

9. Age‐specific genome‐wide association study in glioblastoma identifies increased proportion of ‘lower grade glioma’‐like features associated with younger age

10. Metabolism and Whole-Body Fat Oxidation Following Postexercise Carbohydrate or Protein Intake

11. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

12. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

13. The association between longer relative leukocyte telomere length and risk of glioma is independent of the potentially confounding factors allergy, BMI, and smoking

14. Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk

15. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma

16. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation

17. Adipose tissue and body composition in women six years after gestational diabetes: factors associated with development of type 2 diabetes

18. Genetic Variants in the 9p21.3 Locus Associated with Glioma Risk in Children, Adolescents, and Young Adults: A Case-Control Study

19. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

20. Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

21. Investigation of Established Genetic Risk Variants for Glioma in Prediagnostic Samples from a Population-Based Nested Case–Control Study

22. Comparison of Cardiac Troponins I and T Measured with High-Sensitivity Methods for Evaluation of Prognosis in Atrial Fibrillation: An ARISTOTLE Substudy

23. Sex-specific gene and pathway modeling of inherited glioma risk

24. Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change

25. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis

26. Pregnancy to postpartum transition of serum metabolites in women with gestational diabetes

27. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

28. D‐dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation – observations from the ARISTOTLE trial

29. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

30. High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation

31. High-performance liquid chromatography analysis of ganglioside carbohydrates at the picomole level after ceramide glycanase digestion and fluorescent labeling with 2-aminobenzamide

32. N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo

33. Inhibition of glycogen breakdown by imino sugars in vitro and in vivo

34. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial

35. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy

36. Whole-body fat oxidation increases more by prior exercise than overnight fasting in elite endurance athletes

37. History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

38. Known glioma risk loci are associated with glioma with a family history of brain tumours-A case-control gene association study

39. Genome-wide association study of glioma and meta-analysis

40. Genome-Wide High-Density SNP Linkage Search for Glioma Susceptibility Loci: Results from the Gliogene Consortium

41. Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons

42. Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas

43. Rose hip exerts antidiabetic effects via a mechanism involving downregulation of the hepatic lipogenic program

44. Genetic variations in VEGF and VEGFR2 and glioblastoma outcome

45. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 Genes Involved in the Double-Strand Break Repair Pathway Predict Glioblastoma Survival

46. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk

47. Genetic variations in EGF and EGFR and glioblastoma outcome

48. Metabolic effects of whole grain wheat and whole grain rye in the C57BL/6J mouse

49. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome

50. Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women

Catalog

Books, media, physical & digital resources